GGrantIndex
Sort

39,280 grants matching leukemia

The role of ETV6 in T-cell acute lymphoblastic leukemia

$332,000
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2015 · CA

Targeted Therapy for AML Stem Cells

$332,000
Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

Drug Resistance in Multiple Myeloma

$332,000
William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA

Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL

$332,000
Fatih M Uckun · Children'S Hospital Of Los Angeles · R01 · FY2015 · CA

The role of PHF6 in T-cell acute lymphoblastic leukemia

$332,000
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2015 · CA

Role of autophagy in normal and transformed hematopoietic stem cells

$332,000
Emmanuelle Passegue · Columbia University Health Sciences · R01 · FY2018 · CA

Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1

$332,000
Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2011 · CA

AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia

$332,000
Markus Mãœschen · Children'S Hospital Of Los Angeles · R01 · FY2009 · CA

The role of ETV6 in T-cell acute lymphoblastic leukemia

$332,000
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2013 · CA

The Role of ATM in Suppression of Lymphomas

$332,000
Shan Zha · Columbia University Health Sciences · R01 · FY2015 · CA

Novel Targeted Therapy for AML

$332,000
Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

Interferon Responses in Myeloid Leukemia

$332,000
Serge Y Fuchs · University Of Pennsylvania · R01 · FY2010 · CA

The role of ETV6 in T-cell acute lymphoblastic leukemia

$332,000
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2016 · CA

A Phase I/II Trial of Eltrombopag in Elderly Acute Myeloid Leukemia Patients

$332,000
Martin Carroll · University Of Pennsylvania · R21 · FY2010 · CA

The role of ETV6 in T-cell acute lymphoblastic leukemia

$332,000
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2017 · CA

Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis

$332,000
Christopher Joachim Lengner · University Of Pennsylvania · R01 · FY2016 · CA

AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia

$332,000
Markus Mãœschen · Children'S Hospital Of Los Angeles · R01 · FY2010 · CA

Targeting non-classical oncogenes as therapy for T-ALL

$332,000
Thomas G. Diacovo · Columbia University Health Sciences · R01 · FY2012 · CA

Targeting non-classical oncogenes as therapy for T-ALL

$332,000
Thomas G. Diacovo · Columbia University Health Sciences · R01 · FY2016 · CA

Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor

$331,987
Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2023 · CA

Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor

$331,987
Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2022 · CA

Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp

$331,977
Laurie L Parker · University Of Minnesota · R33 · FY2016 · CA

Ikaros-based epigenetic regulation of T cell leukemogenesis

$331,951
Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2014 · CA

The role of Ndy1 in epigenetic gene silencing and stem cell biology

$331,939
Philip N Tsichlis · Tufts Medical Center · R01 · FY2010 · CA

Cooperating genes in inv (16) acute myeloid leukemia

$331,906
Lucio H. Castilla · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · CA